Glutamate as a new path in discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis
Abstract Background Neuromyelitis optica spectrum disorder (NMOSD) used to be considered as a variant of multiple sclerosis (MS), however the recent detection of a highly specific serum biomarkers for NMOSD have made clear that NMOSD is a condition distinct from MS. The aim was to explore the role o...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-11-01
|
| Series: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Online Access: | https://doi.org/10.1186/s41983-023-00755-y |